Plasma levels of mitochondrial and nuclear DNA in patients with massive pulmonary embolism in the emergency department: A prospective cohort study

Critical Care

Volumn 17, Issue 3, 2013, Pages

  Arnalich, Francisco ^a   Maldifassi, Maria Constanza ^b   Ciria, Enrique ^a   Codoceo, Rosa ^a   Renart, Jaime ^c   Fernández Capitán, Carmen ^a   Herruzo, Rafael ^a   Garcia Rio, Francisco ^a   López Collazo, Eduardo ^a   Montiel, Carmen ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c CSIC   (Spain)

Author keywords

cell free plasma DNA; heart type fatty acid binding protein; hospital mortality; massive pulmonary embolism; plasma mitochondrial DNA; plasma nuclear DNA; prognosis

Indexed keywords

CELL NUCLEUS DNA; MITOCHONDRIAL DNA; BIOLOGICAL MARKER; DNA; FAS ANTIGEN; FAS PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; TROPONIN I;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; EMERGENCY WARD; FEMALE; HEART RIGHT VENTRICLE FAILURE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; LUNG EMBOLISM; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SHOCK; SURVIVAL; APOPTOSIS; BLOOD; EMERGENCY HEALTH SERVICE; FIBRINOLYTIC THERAPY; MIDDLE AGED; PULMONARY EMBOLISM; RISK FACTOR;

AGED; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; DNA; DNA, MITOCHONDRIAL; EMERGENCY SERVICE, HOSPITAL; FATTY ACID-BINDING PROTEINS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RISK FACTORS; THROMBOLYTIC THERAPY; TROPONIN I;

EID: 84878008174     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12735     Document Type: Article

References (43)

1. Konstantinides S. Clinical practice: acute pulmonary embolism. N Engl J Med 2008, 359:2804-2813. 10.1056/NEJMcp0804570, 19109575.
2. Kucher N, Rossi E, De Rosa M, Goldhaber S. Massive pulmonary embolism. Circulation 2006, 113:577-582. 10.1161/CIRCULATIONAHA.105.592592, 16432055.
3. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galiè N, Pruszczyk P, Bengel F, Brady AJ, Ferreira D, Janssens U, Klepetko W, Mayer E, Remy-Jardin M, Bassand JP. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008, 29:2276-2315.
4. Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, Zierler BK. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011, 123:1788-1830. 10.1161/CIR.0b013e318214914f, 21422387.
5. ten Wolde M, Sohne M, Quak E, Mac Gillavry MR, Buller HR. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Intern Med 2004, 164:1685-1689. 10.1001/archinte.164.15.1685, 15302640.
6. Giannitsis E, Katus HA. Risk stratification in pulmonary embolism based on biomarkers and echocardiography. Circulation 2005, 112:1520-1521. 10.1161/CIRCULATIONAHA.105.566182, 16157780.
7. Jiménez D, Aujesky D, Moores L, Gómez V, Martí D, Briongos S, Monreal M, Barrios V, Konstantinides S, Yusen RD. Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax 2011, 66:75-81. 10.1136/thx.2010.150656, 20978032.
8. van der Vaart M, Pretorius PJ. Circulating DNA: its origin and fluctuation. Ann N Y Acad Sci 2008, 1137:18-26. 10.1196/annals.1448.022, 18837919.
9. Peters DL, Pretorius PJ. Origin, translocation and destination of extracellular occurring DNA: a new paradigm in genetic behavior. Clin Chim Acta 2011, 412:806-811. 10.1016/j.cca.2011.01.026, 21277292.
10. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000, 46:319-323.
11. Rainer TH, Wong LK, Lam W, Yuen E, Lam NY, Metreweli C, Lo YM. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 2003, 49:562-569. 10.1373/49.4.562, 12651807.
12. Chang CP, Chia RH, Wu TL, Tsao KC, Sun CF, Wu JT. Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta 2003, 327:95-101. 10.1016/S0009-8981(02)00337-6, 12482623.
13. Chiu TW, Young R, Chan LY, Burd A, Lo DY. Plasma cell-free DNA as an indicator of severity of injury in burn patients. Clin Chem Lab Med 2006, 44:13-17.
14. Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED. Plasma DNA concentration as predictor of mortality and sepsis in critically ill patients. Crit Care 2006, 10:R60. 10.1186/cc4894, 1550922, 16613611.
15. Saukkonen K, Lakkisto P, Varpula M, Varpula T, Voipio-Pulkki L-M, Pettilä V, Pulkki K. Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care patients. Intensive Care Med 2007, 33:1624-1627. 10.1007/s00134-007-0686-z, 17541553.
16. Saukkonen K, Lakkisto P, Pettilä V, Varpula M, Karlsson S, Ruokonen E, Pulkki K. Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem 2008, 54:1000-1007. 10.1373/clinchem.2007.101030, 18420731.
17. Arnalich F, Maldifassi MC, Ciria E, Quesada A, Codoceo R, Herruzo R, Garcia-Cerrada C, Montoya F, Vazquez JJ, López-Collazo E, Montiel C. Usefulness of cell-free plasma DNA to diagnose and predict mortality in patients with suspected acute mesenteric ischemia. Clin Chim Acta 2010, 411:1269-1274. 10.1016/j.cca.2010.05.017, 20478285.
18. Arnalich F, Menéndez M, Lagos V, Ciria E, Quesada A, Codoceo R, Vazquez JJ, López-Collazo E, Montiel C. Prognostic value of cell-free plasma DNA in patients with cardiac arrest outside the hospital: an observational cohort study. Crit Care 2010, 14:R47. 10.1186/cc8934, 2887159, 20350299.
19. Huang CH, Tsai MS, Hsu CY, Chen HW, Wang TD, Chang WT, Ma MH, Chien KL, Chen SC, Chen WJ. Circulating cell-free DNA levels correlate with postresuscitation survival rates in out-of-hospital cardiac arrest patients. Resuscitation 2012, 83:213-218. 10.1016/j.resuscitation.2011.07.039, 21864482.
20. Tsai NW, Lin TK, Chen SD, Chang WN, Wang HC, Yang TM, Lin YJ, Jan CR, Huang CR, Liou CW, Lu CH. The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke. Clin Chim Acta 2011, 412:476-479. 10.1016/j.cca.2010.11.036, 21130757.
21. Lu CH, Chang WN, Tsai NW, Chuang YC, Huang CR, Wang HC. The value of serial plasma and mitochondrial DNA levels in adult community-acquired bacterial meningitis. Q J Med 2010, 103:169-175.
22. Kung CT, Hsiao SY, Tsai TC, Su CM, Chang WN, Huang CR, Wang HC, Lin WC, Chang HW, Lin YJ, Cheng BC, Su BY, Tsai NW, Lu CH. Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room. J Translation Med 2012, 10:130.
23. Arnalich F, Codoceo R, Lopez-Collazo E, Montiel C. Circulating cell-free mitochondrial DNA: a better early prognostic marker in patients with out-of-hospital cardiac arrest. Resuscitation 2012, 83:e162-e163. 10.1016/j.resuscitation.2012.03.032, 22490673.
24. Goldhaber SZ, Hennekens CH, Markisz JA, McNeil BJ, Glynn MA, Bettman MA, Schur PH. Low sensitivity of plasma DNA in screening for pulmonary embolism. Annu Rev Respir Dis 1982, 126:360-361.
25. Vargo JS, Becker DM, Philbrick JT, Schoonover FW, Davis JS. Plasma DNA: a simple, rapid test for aiding the diagnosis of pulmonary embolism. Chest 1990, 97:63-68. 10.1378/chest.97.1.63, 2295262.
26. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004, 305:626-662. 10.1126/science.1099320, 15286356.
27. aujesky D, Obrosky DS, Stone RA, auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005, 172:1041-1046. 10.1164/rccm.200506-862OC, 2718410, 16020800.
28. de Lucas-Cerrillo AM, Maldifassi MC, Arnalich F, Renart J, Atienza G, Serantes R, Cruces J, Sánchez-Pacheco A, Andrés-Mateos E, Montiel C. Function of partially duplicated human α77 nicotinic receptor subunit CHRFAM7A gene: potential implications for the cholinergic anti-inflammatory response. J Biol Chem 2011, 286:594-606. 10.1074/jbc.M110.180067, 3013019, 21047781.
29. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998, 62:768-775. 10.1086/301800, 1377040, 9529358.
30. Chiu RW, Chan LY, Lam NY, Tsui NB, Ng EK, Rainer TH, Lo YM. Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem 2003, 49:719-726. 10.1373/49.5.719, 12709361.
31. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Chronic Kidney Disease Epidemiology Collaboration Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254. 10.7326/0003-4819-145-4-200608150-00004, 16908915, Chronic Kidney Disease Epidemiology Collaboration.
32. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845. 10.2307/2531595, 3203132.
33. Yellow DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007, 357:1121-1135. 10.1056/NEJMra071667, 17855673.
34. Boscheri A, Wunderlich C, Langer M, Schoen S, Wiedemann B, Stolte D, Elmer G, Barthel P, Strasser RH. Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk. Am Heart J 2010, 160:294-300. 10.1016/j.ahj.2010.05.010, 20691835.
35. Dellas C, Puls M, Lankeit M, Schäfer K, Cuny M, Berner M, Hasenfuss G, Konstantinides S. Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism. J Am Coll Cardiol 2010, 55:2150-2157. 10.1016/j.jacc.2009.10.078, 20447541.
36. Mikkelsen ME, Mitiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, Bellamy SL, Christie JD. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009, 37:1670-1677. 10.1097/CCM.0b013e31819fcf68, 19325467.
37. Liu T, Laurell C, Selivanova G, Lundeberg J, Nilsson P, Wiman KG. Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis. Cell Death Differ 2007, 14:411-421. 10.1038/sj.cdd.4402022, 16917513.
38. Iwadate K, Doi M, Tanno K, Katsumura S, Ito H, Sato K, Yonemura I, Ito Y. Right ventricular damage due to pulmonary: examination of the number of infiltrating macrophages. Forensic Sci Int 2003, 134:147-153. 10.1016/S0379-0738(03)00138-5, 12850410.
39. Huttunen R, Kuparinen T, Jylhäva J, Aittoniemi J, Vuento R, Huhtala H, Laine J, Syrjänen J, Hurme M. Fatal outcome in bacteremia is characterized by high plasma cell free DNA concentration and apoptotic DNA fragmentation: a prospective cohort study. PLoS One 2011, 6:e21700. 10.1371/journal.pone.0021700, 3128600, 21747948.
40. Fournie GJ, Martres F, Porrat JP, Alary C, Rumeau M. Plasma DNA as cell death marker in elderly patients. Gerontology 1993, 39:215-221. 10.1159/000213536, 8244049.
41. Gauntier VJ, Tyler LN, Mannik M. Blood clearance kinetics and liver uptake of mononucleosomes in mice. J Immunol 1996, 156:1151-1156.
42. Botezatu I, Serdyuk O, Potapova G, Shelepov V, Alechina R, Molyaka Y, Ananév V, Bazin I, Garin A, Narimanov M, Knysh V, Melkonyan H, Umansky S, Lichtenstein A. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem 2000, 46:1078-1084.
43. Korabecna M, Opatrna S, Jan Wirth J, Rulcova K, Eiselt J, Sefrna F, Horinek A. Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease. Ann N Y Acad Sci 2008, 1137:296-301. 10.1196/annals.1448.014, 18837963.